Company Filing History:
Years Active: 2024
Title: **Innovator Spotlight: Daniel R. Marshall**
Introduction
Daniel R. Marshall, a prominent inventor based in San Mateo, California, has made significant contributions to the field of pharmaceuticals. With a total of two patents to his name, he focuses on developing innovative compounds that target critical health issues.
Latest Patents
Marshall's latest patents involve the creation of aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors. These compounds are characterized by their potential utility in treating diseases or conditions modulated at least in part by CCR6. His other patent features aryl sulfonyl compounds, which are also designed as CCR6 inhibitors, emphasizing the importance of these molecules in therapeutic applications.
Career Highlights
Throughout his career, Daniel has worked with reputable companies such as Chemocentryx, Inc. and Amgen Inc. His experience at these institutions has been pivotal in shaping his innovative approach to drug development.
Collaborations
Marshall has collaborated with notable coworkers, including Penglie Zhang and Howard S. Roth. These partnerships have fostered an environment of creativity and innovation, contributing to the successful development of new pharmaceutical compounds.
Conclusion
Daniel R. Marshall's endeavors in the realm of pharmaceuticals highlight the impact of dedicated inventors in advancing medical science. His work continues to pave the way for potential treatments that could significantly improve health outcomes for various conditions.